2026 Global: Biosensors Market-Competitive Review (2032) report
Description
The 2026 Global: Biosensors Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biosensors market by geography and historical trend. The scope of the report extends to sizing of the biosensors market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biosensors market features dominant players like Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), and Medtronic (Ireland), which collectively hold 35-45% market share through innovations in glucose monitoring and diagnostics. Dexcom, Inc. (US) leads in continuous glucose monitoring (CGM) systems, revolutionizing diabetes management with wearable devices. Bio-Rad Laboratories, Inc. (US) excels in life science tools and clinical diagnostics, leveraging biosensors for precise analyte detection. DuPont (US) contributes advanced materials for electrochemical and optical biosensors, enhancing sensitivity in medical and environmental applications. Siemens Healthineers (Germany) drives point-of-care testing with integrated biosensor platforms for rapid diagnostics. These companies fuel market growth from USD 34.51 billion in 2025 to USD 54.37 billion by 2030 at a 9.5% CAGR, propelled by nanotechnology and chronic disease monitoring.
Universal Biosensors (Australia) specializes in point-of-care diagnostics like blood glucose and coagulation testing using electrochemical sensors. Nova Biomedical (US) provides critical care analyzers with biosensors for real-time blood gas and electrolyte monitoring in hospitals. Biosensors International Group, Ltd. (Singapore) focuses on cardiovascular stents with integrated biosensors and glucose monitoring strips. Johnson & Johnson (via LifeScan, US) dominates diabetes care with OneTouch systems, emphasizing user-friendly blood glucose meters. Recent collaborations, such as Abbott's August 2024 partnership with Medtronic for CGM-insulin integration, underscore strategic expansions. Nix Biosensors (US) innovates wearable hydration and sweat analysis sensors for athletes and health tracking.
Market leaders invest heavily in wearables and point-of-care tech amid rising diabetes prevalence, with Masimo (US) advancing noninvasive pulse oximetry biosensors for oxygen monitoring. i-Sens, Inc. (South Korea) offers affordable glucometers like CareSens, expanding access in emerging markets. Thermo Fisher Scientific (US) integrates biosensors into lab instruments for molecular diagnostics and research. SD Biosensor (South Korea) grows via acquisitions like Meridian Bioscience in 2022, bolstering infectious disease testing. These ten firms—Abbott, Roche, Medtronic, Dexcom, Bio-Rad, DuPont, Siemens, Universal Biosensors, Nova Biomedical, and Biosensors International—navigate a consolidated landscape, prioritizing R&D for non-invasive, real-time solutions amid 8-9% CAGRs through 2032.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biosensors market by geography and historical trend. The scope of the report extends to sizing of the biosensors market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The biosensors market features dominant players like Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), and Medtronic (Ireland), which collectively hold 35-45% market share through innovations in glucose monitoring and diagnostics. Dexcom, Inc. (US) leads in continuous glucose monitoring (CGM) systems, revolutionizing diabetes management with wearable devices. Bio-Rad Laboratories, Inc. (US) excels in life science tools and clinical diagnostics, leveraging biosensors for precise analyte detection. DuPont (US) contributes advanced materials for electrochemical and optical biosensors, enhancing sensitivity in medical and environmental applications. Siemens Healthineers (Germany) drives point-of-care testing with integrated biosensor platforms for rapid diagnostics. These companies fuel market growth from USD 34.51 billion in 2025 to USD 54.37 billion by 2030 at a 9.5% CAGR, propelled by nanotechnology and chronic disease monitoring.
Universal Biosensors (Australia) specializes in point-of-care diagnostics like blood glucose and coagulation testing using electrochemical sensors. Nova Biomedical (US) provides critical care analyzers with biosensors for real-time blood gas and electrolyte monitoring in hospitals. Biosensors International Group, Ltd. (Singapore) focuses on cardiovascular stents with integrated biosensors and glucose monitoring strips. Johnson & Johnson (via LifeScan, US) dominates diabetes care with OneTouch systems, emphasizing user-friendly blood glucose meters. Recent collaborations, such as Abbott's August 2024 partnership with Medtronic for CGM-insulin integration, underscore strategic expansions. Nix Biosensors (US) innovates wearable hydration and sweat analysis sensors for athletes and health tracking.
Market leaders invest heavily in wearables and point-of-care tech amid rising diabetes prevalence, with Masimo (US) advancing noninvasive pulse oximetry biosensors for oxygen monitoring. i-Sens, Inc. (South Korea) offers affordable glucometers like CareSens, expanding access in emerging markets. Thermo Fisher Scientific (US) integrates biosensors into lab instruments for molecular diagnostics and research. SD Biosensor (South Korea) grows via acquisitions like Meridian Bioscience in 2022, bolstering infectious disease testing. These ten firms—Abbott, Roche, Medtronic, Dexcom, Bio-Rad, DuPont, Siemens, Universal Biosensors, Nova Biomedical, and Biosensors International—navigate a consolidated landscape, prioritizing R&D for non-invasive, real-time solutions amid 8-9% CAGRs through 2032.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
